Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents

Journal of Medicinal Chemistry

Volumn 54, Issue 1, 2011, Pages 374-381

  Kumar, Kunal ^a   Awasthi, Divya ^a   Lee, Seung Yub ^a   Zanardi, Ilaria ^a   Ruzsicska, Bela ^a   Knudson, Susan ^b   Tonge, Peter J ^a   Slayden, Richard A ^b   Ojima, Iwao ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 BENZYLOXYCARBONYLAMINO 2 CYCLOHEXYL 6 (PYRROLIDIN 1 YL) 1H BENZO(D)IMIDAZOLE; 5 BUT 3 ENOXYCARBONYLAMINO 2 CYCLOHEXYL 6 N,N DIETHYLAMINO 1H BENZO(D)IMIDAZOLE; 5 BUTOXYCARBONYLAMINO 2 CYCLOHEXYL 6 (PYRROLIDIN 1 YL) 1H BENZO(D)IMIDAZOLE; 7 ACETYLAMINO 5 ETHOXYCARBONYLAMINO 2 PHENYL 1H BENZO(D)IMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; GUANOSINE TRIPHOSPHATASE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG RESISTANCE; DRUG SYNTHESIS; ENZYME ACTIVITY; IC 50; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STRUCTURE ACTIVITY RELATION; VERO CELL;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BENZIMIDAZOLES; CERCOPITHECUS AETHIOPS; CYTOSKELETAL PROTEINS; GTP PHOSPHOHYDROLASES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

EID: 78651094980     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1012006     Document Type: Article

References (29)

1. World Health Organization. Tuberculosis: Data and Country Profiles. http://www.who.int/tb/country/en/.
2. Raviglione, M. C. Issues facing TB control (7). Multiple drug-resistant tuberculosis. Scott. Med. J. 2000, 45 (5, Suppl.), 52 - 55, discussion 56.
3. Gandhi, N. R.; Moll, A.; Sturm, A. W.; Pawinski, R.; Govender, T.; Lalloo, U.; Zeller, K.; Andrews, J.; Friedland, G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 2006, 368 (9547) 1575-1580
4. Errington, J.; Daniel, R. A.; Scheffers, D.-J. Cytokinesis in bacteria Microbiol. Mol. Biol. Rev. 2003, 67 (1) 52-65
5. Bi, E.; Lutkenhaus, J. FtsZ Ring structure associated with division in Escherichia coli Nature 1991, 354, 161-164
6. Vollmer, W. The prokaryotic cytoskeleton: a putative target for inhibitors and antibiotics? Appl. Microbiol. Biotechnol. 2006, 73 (1) 37-47
7. Huang, Q.; Tonge, P. J.; Slayden, R. A.; Kirikae, T.; Ojima, I. FtsZ: a novel target for tuberculosis drug discovery Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2007, 7 (5) 527-543
8. Slayden, R. A.; Knudson, D. L.; Belisle, J. T. Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis Microbiology (Reading, U. K.) 2006, 152 (6) 1789-1797
9. Respicio, L.; Nair, P. A.; Huang, Q.; Burcu, A. B.; Tracz, S.; Truglio, J. J.; Kisker, C.; Raleigh, D. P.; Ojima, I.; Knudson, D. L.; Tonge, P. J.; Slayden, R. A. Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery Tuberculosis 2008, 88, 420-429
10. Nogales, E.; Wang, H. W. Structural mechanisms underlying nucleotide-dependent self-assembly of tubulin and its relatives Curr. Opin. Struct. Biol. 2006, 16, 221-229
11. Farmer, P.; Bayona, J.; Becerra, M.; Furin, J.; Henry, C.; Hiatt, H.; Kim, J. Y.; Mitnick, C.; Nardell, E.; Shin, S. The dilemma of MDR-TB in the global era Int. J. Tuberc. Lung Dis. 1998, 2 (11) 869-876
12. White, E. L.; Ross, L. J.; Reynolds, R. C.; Seitz, L. E.; Moore, G. D.; Borhani, D. W. Slow polymerization of Mycobacterium tuberculosis FtsZ J. Bacteriol. 2000, 182, 4028-4034
13. White, E. L.; Suling, W. J.; Ross, L. J.; Seitz, L. E.; Reynolds, R. C. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ J. Antimicrob. Chemother. 2002, 50 (1) 111-114
14. Reynolds, R. C.; Srivastava, S.; Ross, L. J.; Suling, W. J.; White, E. L. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ Bioorg. Med. Chem. Lett. 2004, 14 (12) 3161-3164
15. Margalit, D. N.; Romberg, L.; Mets, R. B.; Hebert, A. M.; Mitchison, T. J.; Kirschner, M. W.; RayChaudhuri, D. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (38) 13969; erratum to document cited in CA141:271048
16. Urgaonkar, S.; La Pierre, H. S.; Meir, I.; Lund, H.; Ray Chaudhuri, D.; Shaw, J. T. Synthesis of antimicrobial natural products targeting FtsZ: (+-)-dichamanetin and (+-)-2‴-hydroxy-5″-benzylisouvarinol-B Org. Lett. 2005, 7 (25) 5609-5612
17. Rai, D.; Singh, J. K.; Roy, N.; Panda, D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity Biochem. J. 2008, 410 (1) 147-155
18. Domadia, P.; Swarup, S.; Bhunia, A.; Sivaraman, J.; Dasgupta, D. Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde Biochem. Pharmacol. 2007, 74 (6) 831-840
19. Jaiswal, R.; Beuria, T. K.; Mohan, R.; Mahajan, S. K.; Panda, D. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ Biochemistry 2007, 46 (14) 4211-4220
20. Stokes, N. R.; Sievers, J.; Barker, S.; Bennett, J. M.; Brown, D. R.; Collins, I.; Errington, V. M.; Foulger, D.; Hall, M.; Halsey, R.; Johnson, H.; Rose, V.; Thomaides, H. B.; Haydon, D. J.; Czaplewski, L. G.; Errington, J. Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assay J. Biol. Chem. 2005, 280 (48) 39709-39715
21. Ito, H.; Ura, A.; Oyamada, Y.; Tanitame, A.; Yoshida, H.; Yamada, S.; Wachi, M.; Yamagishi, J.-i. A 4-aminofurazan derivative-A189-inhibits assembly of bacterial cell division protein FtsZ in vitro and in vivo Microbiol. Immunol. 2006, 50 (10) 759-764
22. Paradis-Bleau, C.; Beaumont, M.; Sanschagrin, F.; Voyer, N.; Levesque, R. C. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials Bioorg. Med. Chem. 2007, 15 (3) 1330-1340
23. Huang, Q.; Kirikae, F.; Kirikae, T.; Pepe, A.; Amin, A.; Respicio, L.; Slayden, R. A.; Tonge, P. J.; Ojima, I. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents J. Med. Chem. 2006, 49 (2) 463-466
24. Kumar, K.; Lee, S.-Y.; Zanardi, I.; Slayden, R. A.; Ojima, I., Synthesis and Optimization of a Library of Novel Benzimidazole Leads for Antituberculosis Drug Discovery. Presented at the 234th National Meeting of the American Chemical Society, Boston, MA, United States, August 19-23, 2007; MEDI-205.
25. Collins, L.; Franzblau, S. G. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium Antimicrob. Agents Chemother. 1997, 41 (5) 1004-1009
26. Boyne, M. E.; Sullivan, T. J.; amEnde, C. W.; Lu, H.; Gruppo, V.; Heaslip, D.; Amin, A. G.; Chatterjee, D.; Lenaerts, A.; Tonge, P. J.; Slayden, R. A. Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors Antimicrob. Agents Chemother. 2007, 51, 3562-3567
27. Slayden, R. A.; Lee, R. E.; Barry, C. E. Isoniazid effects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis Mol. Microbiol. 2000, 38 (3) 514-525
28. Mukherjee, A.; Lutkenhaus, J. Analysis of FtsZ assembly by light scattering and determination of the role of divalent metal cations J. Bacteriol. 1999, 181 (3) 823-832
29. Geladopoulos, T. P.; Sotiroudis, T. G.; Evangelopoulos, A. E. A Malachite Green colorimetric assay for protein phosphatase activity Anal. Biochem. 1991, 192, 112-116